Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
CALL
Powell Industries
POWL
$6.93B
| $26.1M | ﹤0.01% |
460,200
+267,600
| +139% | +$18.7M |
|
1502
PUT
Emerson Electric
EMR
$86.4B
| $26.1M | ﹤0.01% |
237,800
-165,400
| -41% | -$19.9M |
|
1503
CALL
AGNC Investment
AGNC
$12.9B
| $26.1M | ﹤0.01% |
2,720,800
+1,354,400
| +99% | +$13.5M |
|
|
CMA
1504
CALL
DELISTED
Comerica
CMA
| $26.1M | ﹤0.01% |
441,100
-98,700
| -18% | -$6.2M |
|
1505
CALL
Enovix
ENVX
$742M
| $26M | ﹤0.01% |
4,050,971
-829,600
| -17% | -$7.38M |
|
1506
TG Therapeutics
TGTX
$8.48B
| $26M | ﹤0.01% |
659,660
-167,445
| -20% | -$5.63M |
|
1507
PUT
Whirlpool
WHR
$2.65B
| $26M | ﹤0.01% |
288,300
-212,500
| -42% | -$22.5M |
|
1508
PUT
Capri Holdings
CPRI
$1.51B
| $26M | ﹤0.01% |
1,317,000
+284,700
| +28% | +$6.3M |
|
1509
Innovator US Small Cap Power Buffer ETF April
KAPR
$219M
| $26M | ﹤0.01% |
841,542
+805,482
| +2,234% | +$26M |
|
1510
PUT
Vanguard Real Estate ETF
VNQ
$39.4B
| $26M | ﹤0.01% |
286,700
-43,200
| -13% | -$3.92M |
|
|
1511
PUT
TG Therapeutics
TGTX
$8.48B
| $25.9M | ﹤0.01% |
658,000
-616,200
| -48% | -$20.7M |
|
1512
PUT
Steel Dynamics
STLD
$33.1B
| $25.9M | ﹤0.01% |
207,300
-120,900
| -37% | -$15.3M |
|
1513
UBS Group
UBS
$166B
| $25.8M | ﹤0.01% |
843,711
+580,258
| +220% | +$19.4M |
|
1514
CALL
Scorpio Tankers
STNG
$3.87B
| $25.8M | ﹤0.01% |
687,600
-22,200
| -3% | -$994K |
|
|
OKLO
1515
PUT
Oklo
OKLO
$8.24B
| $25.8M | ﹤0.01% |
1,194,000
-965,900
| -45% | -$32.6M |
|
1516
CALL
Blue Owl Capital
OWL
$18.4B
| $25.8M | ﹤0.01% |
1,286,900
+765,400
| +147% | +$17.2M |
|
1517
Welltower
WELL
$174B
| $25.8M | ﹤0.01% |
168,134
-80,809
| -32% | -$11.5M |
|
1518
PUT
Direxion Daily TSLA Bull 2X ETF
TSLL
$3.65B
| $25.8M | ﹤0.01% |
2,705,600
-2,713,800
| -50% | -$50.1M |
|
1519
Domino's
DPZ
$11.6B
| $25.7M | ﹤0.01% |
55,990
+35,420
| +172% | +$16M |
|
1520
CALL
Insmed
INSM
$27.1B
| $25.6M | ﹤0.01% |
336,000
-1,000
| -0.3% | -$76.5K |
|
1521
Bristol-Myers Squibb
BMY
$139B
| $25.6M | ﹤0.01% |
419,857
-878,257
| -68% | -$51.2M |
|
1522
BridgeBio Pharma
BBIO
$15.7B
| $25.6M | ﹤0.01% |
739,704
-484,578
| -40% | -$16.3M |
|
1523
Danaher
DHR
$152B
| $25.6M | ﹤0.01% |
124,688
-236,983
| -66% | -$51.7M |
|
1524
CALL
Builders FirstSource
BLDR
$7.46B
| $25.5M | ﹤0.01% |
204,400
+3,800
| +2% | +$553K |
|
|
NVMI
1525
PUT
Nova
NVMI
$11.7B
| $25.5M | ﹤0.01% |
138,400
+75,300
| +119% | +$17.4M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.